Hims & Hers Health (HIMS) Common Equity (2019 - 2026)

Hims & Hers Health has disclosed Common Equity across 8 years of filings, most recently posting $324.1 million for Q2 2026.

• In Q2 2026, Common Equity fell 42.41% year-over-year to $324.1 million; the TTM figure through Jun 2026 stood at $324.1 million (down 42.41% YoY), while the FY2025 annual figure was $540.9 million, up 13.47% from the prior year.
• Common Equity came in at $324.1 million for Q2 2026 at Hims & Hers Health, down from $446.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $581.0 million in Q3 2025 to a low of $310.9 million in Q3 2022.
• Average Common Equity over 5 years is $400.1 million, with a median of $344.3 million recorded in 2023.
• Year-over-year, Common Equity surged 59.45% in 2025 and tumbled 42.41% in 2026.
• Over 5 years, Common Equity stood at $311.7 million in 2022, then gained by 10.36% to $344.0 million in 2023, then surged by 38.57% to $476.7 million in 2024, then rose by 13.47% to $540.9 million in 2025, then plunged by 40.09% to $324.1 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $324.1 million in Q2 2026, $446.2 million in Q1 2026, and $540.9 million in Q4 2025.